Elite Laboratories, Inc. et al.; Withdrawal of Approval of 16 Abbreviated New Drug Applications

tunity for a hearing. Withdrawal of approval of an application or abbreviated application under Sec. 314.150(c) is without prejudice to refiling. Table 1--ANDAs for Which Approval Is Withdrawn ------------------------------------------------------------------------ Application No. Drug Applicant ------------------------------------------------------------------------ ANDA 040227............... Phentermine Elite Laboratories, hydrochloride (HCl) Inc., 165/144/135 capsule, 30 Ludlow Ave., milligrams (mg). Northvale, NJ 07647. ANDA 040460............... Phentermine HCl Do. capsule, 15 mg. ANDA 065025............... Cyclosporine AbbVie Inc., 1 N solution, 100 mg/ Waukegan Rd., North milliliters (mL). Chicago, IL 60064. ANDA 075180............... Ranitidine HCl Par Health USA LLC, tablet, Equivalent U.S. Agent for PH to (EQ) 150 mg and Health Limited, 300 EQ 300 mg. Tice Blvd., Suite 230, Woodcliff Lake, NJ 07677. ANDA 076434............... PAROEX (chlorhexidine Sunstar Americas, gluconate) solution, Inc., 301 E Central 0.12%. Rd., Schaumburg, IL 60195. ANDA 090734............... OXYCODONE AND Par Health USA LLC, ACETAMINOPHEN U.S. Agent for PH (acetaminophen; Health Limited, 9 oxycodone HCl) Great Valley tablet, 325 mg; 7.5 Parkway, Malvern, PA mg and 325 mg; 10 mg. 19355. ANDA 204960............... Cisatracurium eVenus Pharmaceutical besylate injectable, Lab Inc., U.S. Agent EQ 2